Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients

Journal of Surgical Oncology
Ting-Shi SuJian-Ning Liang

Abstract

To evaluate the efficacy of stereotactic body radiation therapy (SBRT) in small hepatocellular carcinoma (HCC) patients. From March 2009 to April 2015, we treated 132 small HCC patients with SBRT. Eligibility criteria included longest tumor diameter ≤5.0 cm; Child-Turcotte-Pugh (CTP) Class A or B; unfeasible, difficult or refusal to undergo other surgery or percutaneous ablative therapies; and tumor recurrence after other local treatment. The dose of 42-46 Gy in 3-5 fractions and 28-30 Gy in 1 fraction was prescribed. Of the treated patients, 114 were classified as CTP A and 18 as CTP B. Median tumor size was range 1.1-5.0 cm. The local control rate at 1 years was 90.9%. OS at 1, 3, and 5 years was 94.1%, 73.5%, and 64.3%, respectively. PFS at 1, 3, and 5 years was 82.7%, 58.3%, and 36.4%, respectively. Hepatic toxicity grade ≥3 was observed in 11 patients. Multivariate analysis revealed that CTP B was associated with worse OS (P < 0.001) and multiple nodules were associated with worse PFS (P = 0.001). SBRT is a promising alternative treatment for patients with primary or recurrent small HCC who are unsuitable for surgical resection or local ablative therapy.

Associated Clinical Trials

References

Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·T S LawrenceL F Fajardo
Nov 3, 2009·The Lancet Oncology·Donald PoonUNKNOWN Asian Oncology Summit
Feb 23, 2010·Seminars in Liver Disease·Riccardo Lencioni, Josep M Llovet
Jun 8, 2011·International Journal of Radiation Oncology, Biology, Physics·David L AndolinoHiginia R Cardenes
Feb 22, 2012·International Journal of Radiation Oncology, Biology, Physics·Wen-Yen HuangYao-Wen Chang
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Aug 14, 2012·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Mashaal DhirChandrakanth Are
Dec 12, 2012·Journal of Gastroenterology and Hepatology·Yohji HondaKazuaki Chayama
May 23, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tomoki KimuraYasushi Nagata
Jun 8, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Shaelyn CulletonLaura A Dawson
Aug 8, 2014·Journal of the National Comprehensive Cancer Network : JNCCN·Al B BensonHema Sundar
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal

❮ Previous
Next ❯

Citations

Oct 18, 2019·Yeungnam University Journal of Medicine·Jongmoo ParkMin Kyu Kang
Aug 27, 2016·BioMed Research International·R GallicchioG Storto
Apr 27, 2016·Journal of Surgical Oncology·Han-Yue Mo, Jian-Hong Zhong
Aug 3, 2018·Technology in Cancer Research & Treatment·Stephanie K SchaubSmith Apisarnthanarax
Nov 17, 2019·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Sabine GerumFalk Roeder
Jun 7, 2017·Journal of Applied Clinical Medical Physics·Yong HuZhao-Chong Zeng
May 30, 2019·World Journal of Gastrointestinal Oncology·Sabine GerumFalk Roeder
Jan 13, 2021·Scandinavian Journal of Gastroenterology·Hanna Rahbek MortensenBritta Weber
Jan 6, 2021·Journal of Cancer Research and Clinical Oncology·Luca BoldriniVincenzo Valentini
Nov 18, 2020·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yuichiro TsurugaiYousuke Aoki
Oct 25, 2021·Practical Radiation Oncology·Smith ApisarnthanaraxHiginia Cardenes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.